GET THE APP

Neurological Manifestations in COVID-19 | 93801

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Neurological Manifestations in COVID-19

Author(s): Rohit Wanjari, Abhishek Joshi* and Ashok Mehendale

Abstract

Background: Novel coronavirus infection results in Coronavirus infection (COVID-19) and is termed as “Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)”. Mild to moderate symptoms are being reported in a major proportion of patients suffering from COVID-19 infection, which are mainly respiratory. A large percentage of COVID-19 infected cases are asymptomatic, while few had minor symptoms like rise in temperature, cough, difficulty in breathing, body aches, throat pains etc.

Main text: Although the COVID-19 disease is mainly associated with respiratory symptoms, there can be neurological symptoms in some patients with severe disease. Anosmia has emerged as a predominant feature of SARS-CoV?2. This also arises the probability of some degree of involvement of the CNS with the infection. The mechanisms suggested are that SARS-CoV?2 can enter the CNS via two routes, namely via blood stream or direct spread. Neurological manifestations are seen in patients having prolonged stay in ICU intensive care units. COVID- 19 involves both central nervous system and peripheral nerves. Neurological manifestations of the disease can be due to the neuro-invasiveness of the virus. It can also be an indirect manifestation of multi?organ system failure. The most common neurological manifestation was acute encephalopathy with an incidence of 50%. Manifestations like stroke and coma and also meningitis, encephalitis and myelopathy can occur.

Conclusion: Early diagnosis and management is needed for CNS manifestations as they pose a risk for serious complications. Considering the adverse effects of COVID-19 disease on the central nervous system, more research is needed. This will help evaluate the short and long term effects of SARS-CoV-2 on the functioning of the central nervous system.

Keywords: COVID-19, Nervous system, SARS-CoV-2, Neurological complications, Acute encephalopathy Ischaemic stroke, Guillain-Barre syndrome

Share this article

http://sacs17.amberton.edu/